The FDA approved SYMPAZAN™ (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration, is now available by prescription in all 50 states.
Discover research findings about the public attitudes and beliefs about epilepsy, as well as how likely people with epilepsy are to encounter stigma due to negative public attitudes.
Outcomes from using surgical SLA targeting of subcentimeter-sized EZs, located by rs-fMRI, guided surgery for intractable epilepsy demonstrate the highest seizure freedom rate without surgical complications and are a significant improvement over prior reports.
Neuroene Therapeutics seeks to optimize vitamin K analogues that could improve seizure control in patients with drug-resistant epilepsy.
The C-TIME program can be successfully implemented in the community and is associated with improved outcomes in adults with epilepsy and related mental health conditions.
Living with adult-onset epilepsy can challenge a person's sense of self and trust in their body, resulting in the adoption of various strategies to manage the threat to their identity
CURE is heading to Disneyland for Epilepsy Awareness Day from November 5 – 7, 2018!
Seizure outcome of VNS may be influenced by metabolic connectivity, which can be obtained from preoperative PET imaging.
